Hunan Hansen Pharmaceutical Co., Ltd. (002412.SZ)
CNY 6.27
(0.48%)
CNY 6.27
(0.48%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 178.28 Million | 143.8 Million | 212.53 Million | 162.18 Million | 165.1 Million | 217.51 Million |
| Net Income | 205.01 Million | 167.61 Million | 134.84 Million | 104.82 Million | 159.69 Million | 140.76 Million |
| Depreciation & Amortization | 51.68 Million | 51.58 Million | 51.18 Million | 50.03 Million | 47.6 Million | 45.76 Million |
| Deferred income taxes | -769.08 Thousand | -52.06 Thousand | -457.66 Thousand | -1.39 Million | -922.74 Thousand | -1.22 Million |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -38.98 Million | -34.89 Million | 46.24 Million | 27.42 Million | -38.57 Million | 40.41 Million |
| Other non-cash items | 103.68 Million | -40.5 Million | -19.74 Million | -20.1 Million | -3.61 Million | -9.42 Million |
| Investing Cash Flow | -82.88 Million | -84.49 Million | -172.83 Million | -118.57 Million | -55.23 Million | -127.3 Million |
| Investments in PPE | -19.47 Million | -11.5 Million | -229.33 Million | -129.08 Million | -35.71 Million | -64.53 Million |
| Acquisitions | 352.2 Thousand | 226.22 Thousand | 46.13 Thousand | 129.32 Million | 35.85 Million | 430.91 Thousand |
| Investment purchases | -1.05 Billion | -400.59 Million | -289.83 Million | -25.23 Million | -40 Million | -63.2 Million |
| Sales/Maturities of investments | 993.37 Million | 305.57 Million | 242.05 Million | 35.5 Million | 20.32 Million | - |
| Other Investing Activities | 676.87 Thousand | 21.8 Million | 104.23 Million | -129.08 Million | -35.71 Million | 430.91 Thousand |
| Financing Cash Flow | -179.67 Million | -14.21 Million | -52.94 Million | -56.66 Million | -75.97 Million | -91.42 Million |
| Debt repayment | -25 Million | -161.61 Million | -178 Million | -190.8 Million | -260 Million | -344.96 Million |
| Dividends payments | -150.96 Million | -4.07 Million | -6.58 Million | -37.74 Million | -9.65 Million | -13.43 Million |
| Common Stock Repurchased | - | -1.34 Million | - | - | - | - |
| Common Stock Issuance | - | 1.34 Million | - | - | - | - |
| Other Financing Activities | -3.71 Million | 151.47 Million | 131.63 Million | 179.52 Million | 193.68 Million | 266.97 Million |
| Accounts receivables | -61.77 Million | -35.83 Million | 14.34 Million | 67.42 Million | -32.6 Million | -2.4 Million |
| Accounts payables | 7.56 Million | 7.92 Million | 51.92 Million | -39.3 Million | -12.37 Million | 34.62 Million |
| Inventory | 15.22 Million | -6.93 Million | -19.56 Million | 699.02 Thousand | 7.33 Million | 9.42 Million |
| Other working capital | 6.79 Million | -52.06 Thousand | -457.66 Thousand | -1.39 Million | -922.74 Thousand | 30.98 Million |
| Cash at beginning of period | 145.4 Million | 90.31 Million | 103.56 Million | 116.61 Million | 82.71 Million | 83.93 Million |
| Cash at end of period | 51.12 Million | 135.4 Million | 90.31 Million | 103.56 Million | 116.61 Million | 82.71 Million |
| Capital Expenditure | -19.47 Million | -11.5 Million | -229.33 Million | -129.08 Million | -35.71 Million | -64.53 Million |
| Effect of forex changes on cash | - | - | - | 0.65 | - | - |
| Net cash flow / Change in cash | -94.27 Million | 45.09 Million | -13.24 Million | -13.04 Million | 33.89 Million | -1.21 Million |
| Free Cash Flow | 158.8 Million | 132.3 Million | -16.79 Million | 33.1 Million | 129.39 Million | 152.98 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 30.25 Million | 42.22 Million | 58.26 Million | 95.27 Million | 205.01 Million | 19.07 Million |
| Depreciation & Amortization | - | 9.69 Million | 9.69 Million | 13.63 Million | 51.68 Million | -24.1 Million |
| Deferred income taxes | - | - | - | - | -769.08 Thousand | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | -50.75 Million | - | -46.54 Million | -38.98 Million | 29.99 Million |
| Other non-cash items | 66.23 Million | -10.04 Million | -37 Million | -31.68 Million | 103.68 Million | 25.94 Million |
| Investing Cash Flow | -138.55 Million | 23.08 Million | 570.65 Thousand | -65.68 Million | -82.88 Million | -38.14 Million |
| Investments in PPE | 2.29 Million | -3.44 Million | -5.33 Million | -3.79 Million | -19.47 Million | -3.37 Million |
| Acquisitions | 7135.93 | 2783.19 | - | -25.71 Thousand | 352.2 Thousand | 310.98 Thousand |
| Investment purchases | -385.5 Million | -286.6 Million | -178.9 Million | -284.11 Million | -1.05 Billion | -272.3 Million |
| Sales/Maturities of investments | 244.39 Million | 313.03 Million | 183.67 Million | 221.57 Million | 993.37 Million | 233.21 Million |
| Other Investing Activities | 260.13 Thousand | 100 Thousand | 1.13 Million | 676.87 Thousand | 676.87 Thousand | 4 Million |
| Financing Cash Flow | -5.35 Million | -10.46 Million | 1.83 Million | 1.25 Million | -179.67 Million | -40.03 Million |
| Debt repayment | -10 Million | -10 Million | - | -5 Million | -25 Million | -60 Million |
| Dividends payments | -527.06 Thousand | -323.97 Thousand | -1.16 Million | -742.45 Thousand | -150.96 Million | -150.96 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 5.17 Million | -460.74 Thousand | 1.83 Million | -3.74 Million | -3.71 Million | 20 Million |
| Accounts receivables | - | -56.27 Million | - | -61.77 Million | -61.77 Million | 39.1 Million |
| Accounts payables | - | - | - | - | 7.56 Million | 7.24 Million |
| Inventory | - | 10.07 Million | - | 15.22 Million | 15.22 Million | -9.1 Million |
| Other working capital | - | -4.56 Million | - | - | - | -7.24 Million |
| Cash at beginning of period | 109.9 Million | 74.79 Million | 51.12 Million | 65.6 Million | 145.4 Million | 109.09 Million |
| Cash at end of period | 61.89 Million | 109.9 Million | 74.79 Million | 51.12 Million | 51.12 Million | 65.6 Million |
| Capital Expenditure | 2.29 Million | -3.44 Million | -5.33 Million | -3.79 Million | -19.47 Million | -3.37 Million |
| Effect of forex changes on cash | - | - | - | - | - | -16.21 Million |
| Net cash flow / Change in cash | -48.01 Million | 35.11 Million | 23.66 Million | -14.47 Million | -94.27 Million | -43.49 Million |
| Free Cash Flow | 98.78 Million | 19.04 Million | 15.93 Million | 46.16 Million | 158.8 Million | 47.53 Million |
0853
CSW-B
3934
CTOWY
036830
AMAT